| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |